QuantSoar
HealthcareQuantSoar snapshot generated·Data source: Yahoo Finance·Market data may be delayed
SE

SENS Stock Analysis

NMS · Healthcare · Medical Devices

$10.19

+0.19 (+1.90%)

OverviewTechnicalRiskWhaleEarningsOptionsShort InterestESG

SENS Interactive Price Chart & Trading Signals

SENS Stock Snapshot — Valuation, Risk & Technical Signals

SENS Key Fundamentals, Analyst Targets & Company Profile

Key Financial Ratios

市值

$0.54B

P/E

—

远期P/E

-5.23

PEG

—

P/B

5.97

EPS

$-2.24

股息收益率

—

52周区间

$4.79 – $11.58

贝塔

1.08

成交量

0.2M

ROE

-118.2%

利润率

-225.3%

收入增长

117.8%

毛利率

54.9%

EV/EBITDA

-4.21

分析师目标价

$14.20

Price-to-book is 5.97x. Market capitalization is $538.79M. Revenue is growing at 117.8% on a trailing basis. Beta of 1.08 indicates market-average volatility.

Analyst Consensus

推荐

Buy

目标价（低）

$8.00

目标价（平均）

$14.20

目标价（高）

$18.00

基于5位分析师

关于SENS

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

United States130 员工官网 ↗

在Interactive Brokers交易SENS

低成本全球交易

SENS Deep Dive Analysis

Bottom Line

Verdict

Overvalued

Best for

Growth-oriented investors

Watch out for

Premium valuation

Non-zero inputs

3/5

Counts non-zero values for price, P/E, beta, macro risk, and revenue growth; zero may mean unavailable or be a genuine zero.

Senseonics Holdings, Inc. (SENS) trades above our multi-model fair value estimate of $2.00 by approximately 80.4%. Recent growth metrics show revenue growth of 117.8%. Risk profile: beta of 1.08. Consensus: buy.

Valuation, Growth & Risk

Valuation

Overvalued

Price is above what fundamentals suggest.

Growth

Expanding

Rev 117.8%

Revenue is outpacing the market.

Valuation Snapshot

Senseonics Holdings, Inc. (SENS) trades above our multi-model fair value estimate of $2.00 by approximately 80.4%. Price-to-sales is 11.1x. Price-to-book is 6.0x. Market capitalization is $538.79M.

Why it matters: Paying a premium works only if the company keeps growing faster than expected.

Growth & Profitability

Revenue is growing at 117.8% on a trailing basis.

Why it matters: Growing revenue with healthy margins usually means the business is gaining market share or pricing power.

Risk Profile

Beta of 1.08 indicates market-average volatility. Net debt position is $-79841008.00.

Why it matters: Lower risk means steadier returns, but often with less upside in bull markets.

Analyst Context

Analyst consensus target of $14.20 implies 39.4% upside. Target range spans $8.00 to $18.00. 5 analysts cover the stock. Consensus recommendation: buy.

Why it matters: Analyst targets reflect what professionals expect over 12 months. A wide gap between price and target can mean the market disagrees with the consensus.

Investor Fit

Premium valuation is supported by above-average growth, potentially fitting growth-oriented strategies.

Takeaway: Match the stock's risk-reward profile with your own goals and time horizon. No single metric tells the whole story.

Data Methodology & Sources

Market Data (Facts)

  • Price, volume, and market cap: Yahoo Finance (may be delayed)
  • P/E, EPS, revenue, and debt: Yahoo Finance fundamentals
  • Analyst estimates: Yahoo Finance (coverage and update times vary)
  • Insider transactions: Yahoo Finance (reporting may be delayed)

QuantSoar Model (Derived)

  • Fair value: available outputs from seven models; outliers are filtered using MAD (k=3.5), then combined with fixed model weights.
  • Margin of Safety = (Fair Value − Displayed Price) / Displayed Price × 100
  • Composite Score: 40% Value + 30% Momentum + 30% Risk
  • Verdict Gauge: Base 50 + Valuation (up to ±25) + Whale sentiment (up to ±10) + Insider buying (+5) + Macro risk (up to ±10) + Technical signal (up to ±10). Analyst consensus is separate.

Model outputs are estimates based on available data and are not investment advice. Cross-check with primary sources before making investment decisions.

SENS Overvalued

Senseonics Holdings, Inc. (SENS) trades above our multi-model fair value estimate of $2.00 by approximately 80.4%.

Frequently Asked Questions

ValuationIs SENS stock overvalued right now?
Based on our discounted cash flow and relative valuation models, SENS appears to trade above fair value by approximately 80.4%. This suggests the market may be pricing in elevated growth expectations or sentiment premiums.
ValuationWhat is SENS fair value based on current fundamentals?
Our fair value estimate for SENS is $2.00, derived from discounted cash flow, dividend discount, and relative valuation multiples. The estimate assumes a discount rate of 9.0% and terminal growth of 2.5%.
RiskHow risky is SENS compared with other stocks?
Risk profile for SENS: a beta of 1.08 is near market average. Investors should weigh macro exposure against their own risk tolerance.
GrowthIs SENS still growing?
Latest trailing metrics show revenue growth of 117.8%. Profit margins are not available.
AnalystWhat do analysts think about SENS?
Analyst consensus target is $14.20, implying 39.4% upside. The street recommendation is "buy".
CatalystWhat could change the investment case for SENS?
Key catalysts include Healthcare sector dynamics, interest rate shifts, and company-specific earnings surprises. Monitor macro risk scores and analyst estimate revisions for early signals.

Related Stocks

Healthcare

Explore top stocks in this sector

Explore sector →

Stock valuation guideMacro risk explained guide
Phasakorn Traklang (Peach)

เกี่ยวกับผู้เขียน

Phasakorn Traklang (Peach) — ผู้ก่อตั้ง

ภาสกร ตรากลาง (พีช) เป็นผู้ก่อตั้ง QuantSoar และนักวิจัยการลงทุนเชิงปริมาณที่เชี่ยวชาญด้านการประเมินมูลค่าหุ้นหลายโมเดล การวิเคราะห์กระแสสถาบัน และการสร้างพอร์ตแบบเป็นระบบ เขาสร้างแพลตฟอร์มการเงินที่ขับเคลื่อนด้วยข้อมูลเพื่อให้บริการนักลงทุนรายย่อยทั่วโลก

เชื่อมต่อ LinkedIn

Investment Disclaimer: Tax treatment can depend on tax residence, account type, and tax year. This information is general and is not personal tax or investment advice. SEC

数据来源: Yahoo Finance / SEC EDGAR / Alpha Vantage / Finnhub